Vanda Pharmaceuticals financials at a glance

Year Year 2022 2021 2023 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2005 2024
Rev. Revenue
$254.38M $268.68M $192.64M $0.00M $0.00M $0.00M $4.55M $35.71M $31.27M $32.73M $33.88M $50.16M $109.93M $146.02M $165.08M $193.12M $227.19M $248.17M $0.00M $0.00M
GM % Gross Margin %
90.45% 90.46% 92.32% 0.00% 0.00% 0.00% 57.89% 91.90% 100.00% 99.61% 100.00% 96.84% 78.66% 83.08% 89.19% 89.38% 89.22% 90.59% 0.00% 0.00%
OM Operating Margin
2.49% 15.69% -7.24% 0.00% 0.00% 0.00% 0.00% 24.75% -34.24% -89.16% -62.58% -114.75% -36.56% -12.72% -10.24% 11.26% 10.04% 10.98% 0.00% 0.00%
EPS Earnings Per Share
$-3.97 $-2.81 $-1.92 $-1.33 $0.25 $-0.35 $-0.98 $-0.67 $-1.65 $-0.94 $-0.41 $-0.07 $0.76 $2.38 $0.58 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0.00% 0 -0.00% 0 0 -0.00% 0.00% 0 0 0 0 0 0 0 0.00% 0.00% 0 0 0
Sha. Shares
56.49m 55.71m 57.53m 21.91m 26.65m 26.65m 27.2m 28.04m 28.12m 28.23m 33.19m 41.46m 42.82m 43.95m 44.93m 52.45m 53.34m 54.69m 0m 57.54m
OCF Operating Cash Flow
$31.98M $64.21M $12.80M $-51.62M $-51.64M $-45.96M $169.34M $-10.90M $-28.41M $-44.92M $-39.59M $-81.55M $12.45M $-8.10M $-1.98M $29.99M $45.95M $51.78M $-17.71M $0.00M
FCF Free Cash Flow
$31.30M $63.66M $12.52M $-52.97M $-51.92M $-46.90M $0.00M $0.00M $-28.69M $-46.93M $-39.77M $-82.32M $9.92M $-9.51M $-3.64M $29.62M $44.93M $49.98M $-18.00M $0.00M
FCFS Free Cash Flow Per Share
$0.55 $1.15 $-1.54 $-3.31 $-1.97 $-1.76 $5.82 $-0.39 $-1.02 $-1.66 $-1.31 $-2.60 $0.23 $-0.22 $-0.08 $0.09 $0.85 $0.92 $-1059.06 $0.00